Positive News Topic

Hypertension — Good News & Uplifting Stories

Read the latest positive news, breakthroughs, and inspiring stories about hypertension, curated daily by BrightWire.

9 stories tagged with "Hypertension"
Health & Wellness•May 19

FDA Approves First New Hypertension Drug in 20 Years

Millions of Americans with stubborn high blood pressure just got their first new treatment option in two decades. The FDA has approved Baxfendy, a groundbreaking medication that lowers blood pressure in an entirely new way.

Health & Wellness Desk•2 min read
UAE First to Approve Needle-Free Allergy Treatment
Health & Wellness•May 18

UAE First to Approve Needle-Free Allergy Treatment

The UAE just became the first country in the world to approve a groundbreaking blood pressure treatment and the first in its region to greenlight a needle-free rescue spray for severe allergies. These approvals cement the nation's position as a global leader in getting life-changing medicines to patients fast.

Google News - Uae Innovation•2 min read
4 Breakthrough Treatments Could Launch This Spring
Health & Wellness•Apr 17

4 Breakthrough Treatments Could Launch This Spring

Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.

Google News - New Treatment•3 min read
Twice-Yearly Shot Lowers Blood Pressure for Millions
Health & Wellness•Apr 13

Twice-Yearly Shot Lowers Blood Pressure for Millions

A new injection given just twice a year significantly lowered blood pressure in patients whose condition wasn't controlled by daily pills. The breakthrough could transform care for the 1 in 3 adults living with hypertension.

Science Daily•3 min read
Team Care Cuts High Blood Pressure in Low-Income Patients
Health & Wellness•Apr 9

Team Care Cuts High Blood Pressure in Low-Income Patients

A new study shows that combining home monitoring, health coaching, and medication adjustments helps low-income Americans finally control their high blood pressure. More than half of Americans with hypertension currently can't get it under control, despite having access to affordable medications.

STAT News•2 min read
New Pill Drops Blood Pressure When Standard Drugs Fail
Health & Wellness•Apr 4

New Pill Drops Blood Pressure When Standard Drugs Fail

A breakthrough medication called baxdrostat is giving hope to millions whose dangerously high blood pressure won't respond to standard treatments. The pill dropped blood pressure by nearly 10 points in a major trial, enough to significantly reduce heart attack and stroke risk.

Google News - New Treatment•3 min read
New Pill Cuts Stubborn High Blood Pressure by 10 Points
Health & Wellness•Apr 4

New Pill Cuts Stubborn High Blood Pressure by 10 Points

A breakthrough medication called baxdrostat is giving hope to hundreds of millions of people whose dangerously high blood pressure won't respond to standard treatments. The pill targets a key hormone that causes the body to retain salt and water, lowering blood pressure enough to significantly reduce the risk of heart attacks and strokes.

Google News - New Treatment•3 min read
Twice-Yearly BP Shot Could Replace Daily Pills for Millions
Health & Wellness•Feb 16

Twice-Yearly BP Shot Could Replace Daily Pills for Millions

Scientists have found that two injections per year could control high blood pressure as effectively as daily pills, potentially transforming care for over a billion people worldwide. The treatment is now in late-stage global trials.

Google News - Health Breakthrough•2 min read
Researchers Study Apple Watch Hypertension Feature
Health & Wellness•Feb 12

Researchers Study Apple Watch Hypertension Feature

Scientists are taking a closer look at Apple's new hypertension detection feature to verify its accuracy. The research could help millions monitor their blood pressure more easily from their wrists.

STAT News•2 min read